TICKERNOMICS Sign up
Last Update: 2024-12-27 15:28:14
CRYO CELL INTERNATIONAL INC ( CCEL ) https://www.cryo-cell.com
7.80USD
Sector:
Healthcare
Industry:
Medical Care Facilities
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
CCEL
48.65%
SPY
32.66%
-9.90%
CCEL
SPY
108.59%
CCEL
48.51%
SPY
302.52%
CCEL
337.65%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
63.18
73.17
0.02
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-7.08
1.98
-6.61
15.41
12.94
11.54
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
17.23
73.65
19.64
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
6.344
8.54
11.64
0.55
Other Earnings and Cash Flow Stats:
CRYO CELL INTERNATIONAL INC ( CCEL ) Net Income TTM ($MM) is 4.21
CRYO CELL INTERNATIONAL INC ( CCEL ) Operating Income TTM ($MM) is 5.56
CRYO CELL INTERNATIONAL INC ( CCEL ) Owners' Earnings Annual ($MM) is 0.00
CRYO CELL INTERNATIONAL INC ( CCEL ) Current Price to Owners' Earnings ratio is 0.00
CRYO CELL INTERNATIONAL INC ( CCEL ) EBITDA TTM ($MM) is 6.34
CRYO CELL INTERNATIONAL INC ( CCEL ) EBITDA Margin is 19.64%
Capital Allocation:
CRYO CELL INTERNATIONAL INC ( CCEL ) has paid 1.00 dividends per share and bought back 0.167304 million shares in the past 12 months
CRYO CELL INTERNATIONAL INC ( CCEL ) has increased its debt by 0.993043 million USD in the last 12 months
Capital Structure:
CRYO CELL INTERNATIONAL INC ( CCEL ) Interest-bearing Debt ($MM) as of last quarter is 12
CRYO CELL INTERNATIONAL INC ( CCEL ) Annual Working Capital Investments ($MM) are -1
CRYO CELL INTERNATIONAL INC ( CCEL ) Book Value ($MM) as of last quarter is -10
CRYO CELL INTERNATIONAL INC ( CCEL ) Debt/Capital as of last quarter is -127%
Other Balance Sheet Stats:
CRYO CELL INTERNATIONAL INC ( CCEL ) has 0 million in cash on hand as of last quarter
CRYO CELL INTERNATIONAL INC ( CCEL ) has 17 million of liabilities due within 12 months, and long term debt 10 as of last quarter
CRYO CELL INTERNATIONAL INC ( CCEL ) has 8 common shares outstanding as of last quarter
CRYO CELL INTERNATIONAL INC ( CCEL ) has 0 million USD of preferred stock value
Academic Scores:
CRYO CELL INTERNATIONAL INC ( CCEL ) Altman Z-Score is 0.56 as of last quarter
CRYO CELL INTERNATIONAL INC ( CCEL ) Piotroski Score is 8.00 as of last quarter
Corporate Governance:
CRYO CELL INTERNATIONAL INC ( CCEL ) largest shareholder is JPMORGAN CHASE & CO owning 11 shares at 0.00 ($MM) value
(an insider) shares of CRYO CELL INTERNATIONAL INC ( CCEL ) for the amount of $ on
47.71% of CRYO CELL INTERNATIONAL INC ( CCEL ) is held by insiders, and 11.18% is held by institutions
CRYO CELL INTERNATIONAL INC ( CCEL ) went public on 1997-01-21
Other CRYO CELL INTERNATIONAL INC ( CCEL ) financial metrics:
FCF:8.47
Unlevered Free Cash Flow:0.00
EPS:0.51
Operating Margin:17.23
Gross Profit Margin:73.65
Div. Payout Ratio%:-91.57
Div. Growth YoY%:11.11
Equity Return%:-44.01
Beta:0.55
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About CRYO CELL INTERNATIONAL INC ( CCEL ) :
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.